Dumayo, Venancio O.
HRN: 16-37-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2024
CEFTAZIDIME 1GM (VIAL)
09/28/2024
10/04/2024
IV
1g
Q8h
CAP- MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes